| Snowflake Score | |
|---|---|
| Valuation | 6/6 |
| Future Growth | 5/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 4/6 |
Rewards
Risk Analysis
Selçuk Ecza Deposu Ticaret ve Sanayi A.S. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₺45.26 |
| 52 Week High | ₺69.20 |
| 52 Week Low | ₺31.82 |
| Beta | 0.11 |
| 1 Month Change | -10.46% |
| 3 Month Change | -16.95% |
| 1 Year Change | 30.73% |
| 3 Year Change | 422.63% |
| 5 Year Change | 840.96% |
| Change since IPO | 1,541.52% |
Recent News & Updates
Recent updates
Shareholder Returns
| SELEC | TR Healthcare | TR Market | |
|---|---|---|---|
| 7D | -7.6% | 8.0% | 3.3% |
| 1Y | 30.7% | 140.7% | 113.5% |
Return vs Industry: SELEC underperformed the TR Healthcare industry which returned 140.7% over the past year.
Return vs Market: SELEC underperformed the TR Market which returned 113.5% over the past year.
Price Volatility
| SELEC volatility | |
|---|---|
| SELEC Average Weekly Movement | 6.2% |
| Healthcare Industry Average Movement | 7.0% |
| Market Average Movement | 7.5% |
| 10% most volatile stocks in TR Market | 10.8% |
| 10% least volatile stocks in TR Market | 5.5% |
Stable Share Price: SELEC's share price has been volatile over the past 3 months.
Volatility Over Time: SELEC's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1958 | 6,025 | n/a | www.selcukecza.com.tr |
Selçuk Ecza Deposu Ticaret ve Sanayi A.S. operates as a pharmacy depot and organizes distribution channels between drug manufacturers, hospitals, and pharmacies. It also operates pharmaceutical warehouses. In addition, the company distributes cosmetics, personal care, infant food, vitamins, medical, and other products.
Selçuk Ecza Deposu Ticaret ve Sanayi A.S. Fundamentals Summary
| SELEC fundamental statistics | |
|---|---|
| Market cap | ₺29.46b |
| Earnings (TTM) | -₺163.57m |
| Revenue (TTM) | ₺93.87b |
0.3x
P/S Ratio-180.1x
P/E RatioIs SELEC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SELEC income statement (TTM) | |
|---|---|
| Revenue | ₺93.87b |
| Cost of Revenue | ₺84.56b |
| Gross Profit | ₺9.31b |
| Other Expenses | ₺9.47b |
| Earnings | -₺163.57m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.25 |
| Gross Margin | 9.92% |
| Net Profit Margin | -0.17% |
| Debt/Equity Ratio | 24.8% |
How did SELEC perform over the long term?
See historical performance and comparison